Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
Saved in:
| Title: | Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells. |
|---|---|
| Authors: | Matsuzawa, Fumihiko1 (AUTHOR), Kamachi, Hirofumi1 (AUTHOR) hkamachi@db3.so-net.ne.jp, Mizukami, Tatsuzo1 (AUTHOR), Einama, Takahiro2 (AUTHOR), Kawamata, Futoshi1 (AUTHOR), Fujii, Yuki1 (AUTHOR), Fukai, Moto1 (AUTHOR), Kobayashi, Nozomi1 (AUTHOR), Hatanaka, Yutaka3 (AUTHOR), Taketomi, Akinobu1 (AUTHOR) |
| Source: | BMC Cancer. Dec2021, Vol. 21 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
